Glycolide Lactide Caprolactone Terpolymer: Comprehensive Analysis Of Composition, Properties, And Biomedical Applications

Molecular Composition And Structural Characteristics Of Glycolide Lactide Caprolactone Terpolymer

The glycolide lactide caprolactone terpolymer is synthesized via ring-opening polymerization of three distinct cyclic monomers: glycolide (1,4-dioxane-2,5-dione), lactide (3,6-dimethyl-1,4-dioxane-2,5-dione in its L-, D-, or D,L- stereoisomeric forms), and ε-caprolactone (hexano-6-lactone). The resulting terpolymer exhibits a random or block distribution of repeat units depending on the polymerization strategy employed 4,6. The molecular architecture can be tailored by selecting initiators such as stannous octoate or aluminum alkoxides, which control the polymerization kinetics and final molecular weight distribution 8,17.

Key Structural Features:

• Monomer Ratio Flexibility: Typical compositions range from 20–75 mol% lactide, 10–30 mol% glycolide, and 15–50 mol% caprolactone, enabling precise tuning of polymer properties 2,10. For instance, a terpolymer with 50–85 mol% glycolic acid, 5–30 mol% lactic acid, and 5–30 mol% caprolactone content has been optimized for barrier coating applications 13.

• Glass Transition Temperature (Tg): The incorporation of caprolactone, which has a homopolymer Tg of approximately -60°C, significantly reduces the overall Tg of the terpolymer. Formulations with ≥25 mol% caprolactone achieve Tg values between 25°C and 30°C, well below physiological temperature (37°C), ensuring flexibility and permeation-controlled drug release in vivo 10,2.

• Crystallinity Control: The random distribution of the three monomers disrupts the regular chain packing required for crystallization. Terpolymers based on D-lactide, L-lactide, and ε-caprolactone exhibit limited or no crystallization capacity during hydrolytic degradation, which is critical for maintaining consistent mechanical properties and degradation profiles 14,15.

• Molecular Weight: Inherent viscosity (IV) typically ranges from 0.5 to 1.45 dL/g (measured in hexafluoroisopropanol at 25°C), corresponding to weight-average molecular weights (Mw) of 30,000–150,000 g/mol 18. Higher molecular weights correlate with improved tensile strength and elongation at break, essential for load-bearing surgical applications.

The chemical structure can be represented as a random terpolymer: [-O-CH2-CO-]m[-O-CH(CH3)-CO-]n[-O-(CH2)5-CO-]p, where m, n, and p denote the molar fractions of glycolide, lactide, and caprolactone units, respectively. The sequence distribution profoundly influences hydrolytic degradation kinetics, as glycolide-rich segments degrade faster due to higher hydrophilicity, while caprolactone-rich segments provide long-term mechanical integrity 4,6.

Synthesis Routes And Polymerization Strategies For Glycolide Lactide Caprolactone Terpolymer

The synthesis of glycolide lactide caprolactone terpolymer employs ring-opening polymerization (ROP), a versatile method that allows precise control over monomer sequence, molecular weight, and end-group functionality. Two primary strategies are utilized: single-stage bulk polymerization and two-stage prepolymer-based polymerization 3,18.

Single-Stage Bulk Polymerization:

In this approach, all three monomers (glycolide, lactide, and ε-caprolactone) are combined in a single reactor with a catalyst (typically stannous octoate, Sn(Oct)2, at 0.01–0.1 wt%) and polymerized at 130–180°C under inert atmosphere (nitrogen or argon) for 6–24 hours 4,8. The reaction proceeds via coordination-insertion mechanism, where the metal alkoxide initiator opens the lactone rings and inserts them into the growing polymer chain. Key process parameters include:

• Temperature: 130–160°C for lactide-rich formulations; 160–180°C for glycolide-rich formulations to ensure complete monomer conversion 17.
• Monomer Feed Ratio: Determines the final terpolymer composition; deviations of ±2 mol% from target ratios are common due to differential reactivity (glycolide > lactide > caprolactone) 18.
• Reaction Time: 12–24 hours to achieve >95% monomer conversion and minimize residual monomer content (<1 wt%) 8.

Two-Stage Prepolymer-Based Polymerization:

This method involves first synthesizing a low-molecular-weight prepolymer (Mw ~5,000–10,000 g/mol) of ε-caprolactone and glycolide at 130–150°C for 4–8 hours, followed by addition of lactide monomer and further polymerization at 160–180°C for 8–16 hours 3,18. This sequential approach offers several advantages:

• Enhanced Miscibility: The prepolymer acts as a compatibilizer, improving the homogeneity of the final terpolymer and reducing phase separation 3.
• Controlled Sequence Distribution: By adjusting the prepolymer composition and the timing of lactide addition, block-like or gradient terpolymer architectures can be achieved 9.
• Improved Mechanical Properties: Two-stage polymerization yields terpolymers with 15–25% higher tensile strength and 30–50% greater elongation at break compared to single-stage products 3,7.

Alternative Synthesis Routes:

Recent patents describe the use of monomer-dimer mixtures (e.g., L-lactic acid monomer, glycolic acid monomer, and ε-caprolactone monomer) polymerized via direct polycondensation at 140–160°C under reduced pressure (0.1–1 mmHg) for 24–48 hours 4. This route eliminates the need for cyclic dimer purification but typically results in lower molecular weights (Mw ~20,000–50,000 g/mol) and broader polydispersity indices (PDI 1.8–2.5) 4.

Catalyst Selection And Residual Metal Content:

Stannous octoate remains the most widely used catalyst due to its high activity and FDA approval for biomedical applications. However, residual tin content must be minimized to <50 ppm to avoid cytotoxicity 8,17. Alternative catalysts such as aluminum isopropoxide and zinc lactate have been explored but exhibit slower polymerization rates and require higher loadings (0.5–1.0 wt%) 4.

Physical And Mechanical Properties Of Glycolide Lactide Caprolactone Terpolymer

The physical and mechanical properties of glycolide lactide caprolactone terpolymer are highly dependent on monomer composition, molecular weight, and thermal history. These properties are critical for determining the suitability of the terpolymer for specific biomedical applications.

Thermal Properties:

• Glass Transition Temperature (Tg): Terpolymers with 25–50 mol% caprolactone exhibit Tg values of 25–37°C, as measured by differential scanning calorimetry (DSC) at a heating rate of 10°C/min 2,10. This low Tg ensures that the polymer remains in a rubbery state at body temperature, providing flexibility and elasticity essential for soft tissue applications.

• Melting Temperature (Tm): Glycolide-rich terpolymers (>50 mol% glycolide) display a melting endotherm at 180–220°C, corresponding to the crystalline glycolide domains 18. In contrast, terpolymers with balanced compositions (30–40 mol% each monomer) are predominantly amorphous and exhibit no distinct Tm 14,15.

• Crystallinity: Wide-angle X-ray diffraction (WAXD) analysis reveals crystallinity levels of 10–50% for glycolide-rich terpolymers, while caprolactone-rich formulations (<20 mol% glycolide) show <10% crystallinity 18. The degree of crystallinity inversely correlates with degradation rate, as amorphous regions are more susceptible to hydrolytic attack.

Mechanical Properties:

• Tensile Strength: Ranges from 15 to 60 MPa depending on composition and molecular weight. Terpolymers with 50–70 mol% glycolide and Mw >80,000 g/mol achieve tensile strengths of 50–60 MPa, suitable for load-bearing sutures and orthopedic fixation devices 1,3,7.

• Elongation At Break: Caprolactone content directly enhances ductility; terpolymers with 30–50 mol% caprolactone exhibit elongation at break of 300–800%, compared to 10–50% for glycolide/lactide copolymers 3,7. This high elongation is critical for applications requiring cyclic flexing, such as vascular grafts and hernia meshes.

• Elastic Modulus: Ranges from 0.5 to 2.5 GPa. Glycolide-rich terpolymers (>60 mol% glycolide) exhibit moduli of 2.0–2.5 GPa, providing rigidity for bone screws and plates, while caprolactone-rich formulations (>40 mol% caprolactone) show moduli of 0.5–1.0 GPa, ideal for flexible drug delivery depots 1,10.

• Impact Resistance: Two-stage polymerized terpolymers demonstrate 40–60% higher impact strength (measured by Izod impact test at 23°C) compared to single-stage products, attributed to improved phase homogeneity and reduced brittleness 3,7.

Viscosity And Processability:

The intrinsic viscosity of glycolide lactide caprolactone terpolymer solutions (0.1 g/dL in hexafluoroisopropanol at 25°C) ranges from 0.5 to 1.45 dL/g 18. For drug delivery applications, terpolymers with IV ~0.8–1.2 dL/g can be formulated as viscous liquids (10,000–50,000 cP at 25°C) by dissolving in biocompatible solvents such as N-methylpyrrolidone (NMP) or ethanol at 30–50 wt% polymer concentration 8,17. These viscous formulations enable minimally invasive injection and in situ depot formation.

Sterilization Stability:

Ethylene oxide (ETO) sterilization and e-beam irradiation (25–50 kGy) are commonly employed for terminal sterilization of terpolymer-based devices. Terpolymers with Tg <37°C and balanced monomer compositions maintain coating integrity and mechanical properties post-sterilization, whereas glycolide-rich formulations may undergo chain scission and 10–20% reduction in molecular weight 2.

Hydrolytic Degradation Kinetics And Mechanisms In Glycolide Lactide Caprolactone Terpolymer

The biodegradation of glycolide lactide caprolactone terpolymer proceeds via bulk hydrolysis of ester linkages, a process influenced by monomer composition, crystallinity, molecular weight, and environmental conditions (pH, temperature, enzyme presence). Understanding degradation kinetics is essential for designing devices with predictable resorption profiles.

Degradation Mechanism:

Hydrolytic cleavage of ester bonds generates carboxylic acid and hydroxyl end groups, which autocatalyze further degradation by lowering local pH 4,6. The degradation rate follows the order: glycolide > lactide > caprolactone, due to differences in hydrophilicity and steric hindrance 8,17. In terpolymers, glycolide-rich domains degrade preferentially, creating porous structures that accelerate water ingress and overall mass loss.

Degradation Rate Modulation:

• Monomer Composition: Terpolymers with 50–70 mol% glycolide exhibit 50–80% mass loss within 3–6 months in phosphate-buffered saline (PBS, pH 7.4, 37°C), while caprolactone-rich formulations (>40 mol% caprolactone) require 12–24 months for equivalent mass loss 2,10.

• Crystallinity: Amorphous terpolymers degrade 2–5 times faster than semicrystalline counterparts due to greater water accessibility 14,15. Random terpolymers based on D-lactide, L-lactide, and ε-caprolactone, which resist crystallization during degradation, maintain consistent mechanical properties until >60% mass loss 14,15.

• Molecular Weight: Higher molecular weight terpolymers (Mw >100,000 g/mol) exhibit longer lag phases (1–3 months) before significant mass loss, whereas lower molecular weight formulations (Mw <50,000 g/mol) begin degrading within weeks 4,6.

• Device Geometry: Thin coatings (<10 μm) on stents degrade faster than bulk devices (>1 mm thickness) due to higher surface area-to-volume ratios and reduced autocatalytic effects 2,10.

Degradation Products And Biocompatibility:

The primary degradation products—glycolic acid, lactic acid, and 6-hydroxyhexanoic acid—are metabolized via the Krebs cycle or excreted renally, ensuring non-toxicity 4,6. In vivo studies in rats and rabbits demonstrate minimal inflammatory response (fibrous capsule thickness <50 μm at 12 weeks) and complete resorption within 6–24 months depending on composition 1,3,7.

Accelerated Degradation Testing:

Accelerated degradation at elevated temperatures (50–70°C) or alkaline pH (pH 10–12) is used to predict long-term performance. Arrhenius modeling indicates that degradation rates increase by a factor of 2–3 for every 10°C rise in temperature 18. However, such tests may not accurately reflect in vivo conditions due to differences in enzyme activity and mechanical loading.

Applications Of Glycolide Lactide Caprolactone Terpolymer In Biomedical Devices

Glycolide lactide caprolactone terpolymer has been extensively adopted in diverse biomedical applications due to its tunable properties and proven biocompatibility. The following sections detail specific use cases, performance requirements, and clinical outcomes.

Absorbable Surgical Sutures And Fixation Devices

Terpolymer-based sutures and orthopedic fixation devices (screws, plates, anchors) leverage the material's high tensile strength and controlled degradation. Polymer blends of glycolide/lactide copolymer and polycaprolactone homopolymer, or terpolymers with 50–70 mol% glycolide, 20–30 mol% lactide, and 10–20 mol% caprolactone, exhibit tensile strengths of 50–70 MPa and retain >80% strength for 4–6 weeks post-implantation, sufficient for bone healing 1,3,7. These devices degrade completely within 6–12 months, eliminating the need for removal surgery. Clinical studies report <5% complication rates (infection, foreign body reaction) in over 10,000 patients undergoing ACL reconstruction with terpolymer interference screws 1,7.

Key Performance Metrics: